Al-Sheikh Haifa, Al-Sunaid Mohammed, Alrajhi Abdulrahman A
Dr. Abdulrahman A. Alrajhi, Department of Medicine,, King Faisal Specialist Hospital and Research Centre,, MBC#46 PO Box 3354,, Riyadh 11211, Saudi Arabia,
Ann Saudi Med. 2013 Jul-Aug;33(4):347-50. doi: 10.5144/0256-4947.2013.347.
Human immunodeficiency virus-associated nephropathy (HIVAN) is the most common cause of chronic renal failure in HIV patients with African descent. It usually presents with proteinuria, enlarged kidneys, and rapidly progressive renal failure, often over several weeks to months. We conducted this study to determine the prevalence of HIVAN in our HIV population.
Cross-sectional observational study in a referral center covering the period of 1990- 2010.
Proteinuria and estimated glomerular filtration rate (e-GFR) were used to identify renal disease and suspicious cases of HIVAN with abnormal proteinuria and e-GFR of < 60 mL/min/1.73 m2.
Of 585 HIV-positive patients, 248 were eligible to inclusion criteria. Most of the patients were male, that is, 165 (67%) were male compared to 83 (33%) female with the mean age 39 years; 240 (96.7%) were on antiretroviral therapy. Thirty (12%) patients had abnormal proteinuria and 218 (88%) had normal urinary protein and e-GFR. No significant differences were observed in demographic data, CD4+ T-lymphocyte count, viral load, creatinine level, and e-GFR among both groups. Significant differences were observed in the prevalence of diabetes mellitus in the abnormal proteinuria group (10 patients [33.3%] compared to 30 patients [13.8%] in the normal group (P=.0139) and the prevalence of hypertension in the abnormal proteinuria group (11 patients [36.7%] compared to 22 patients [10%] in the normal group (P=.002). Sixteen patients (6.6% of the cohort) met the study definition of HIVAN.
The prevalence of abnormal proteinuria and HIVAN among HIV-infected patients in Saudi Arabia is higher than that of non-African patients in developed countries.
人类免疫缺陷病毒相关性肾病(HIVAN)是非洲裔HIV患者慢性肾衰竭的最常见病因。其通常表现为蛋白尿、肾脏肿大以及迅速进展的肾衰竭,往往在数周或数月内发生。我们开展本研究以确定HIVAN在我们HIV人群中的患病率。
在一家转诊中心进行的1990年至2010年期间的横断面观察性研究。
蛋白尿和估算肾小球滤过率(e-GFR)用于识别肾脏疾病以及蛋白尿异常且e-GFR<60 mL/(min·1.73 m²)的HIVAN可疑病例。
在585例HIV阳性患者中,248例符合纳入标准。大多数患者为男性,即165例(67%)为男性,83例(33%)为女性,平均年龄39岁;240例(96.7%)正在接受抗逆转录病毒治疗。30例(12%)患者蛋白尿异常,218例(88%)患者尿蛋白和e-GFR正常。两组在人口统计学数据、CD4⁺T淋巴细胞计数、病毒载量、肌酐水平和e-GFR方面未观察到显著差异。在异常蛋白尿组中糖尿病患病率(10例患者[33.3%])与正常组中30例患者(13.8%)相比存在显著差异(P = 0.0139),并且异常蛋白尿组中高血压患病率(11例患者[36.7%])与正常组中22例患者(10%)相比存在显著差异(P = 0.002)。16例患者(占队列的6.6%)符合HIVAN的研究定义。
沙特阿拉伯HIV感染患者中异常蛋白尿和HIVAN的患病率高于发达国家的非非洲裔患者。